Ashland, MA, United States of America

Vivek Prabhakar Raut

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Arteriocyte Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vivek Prabhakar Raut: Innovator in Wound Care Technology

Introduction

Vivek Prabhakar Raut is an accomplished inventor based in Ashland, MA (US). He has made significant contributions to the field of medical technology, particularly in wound care. His innovative approach has led to the development of a unique dressing that incorporates advanced materials for enhanced healing.

Latest Patents

Vivek holds a patent for "Dressings comprising platelet lysate." This dressing features a delivery vehicle and platelet lysate, which can be combined with an antimicrobial agent, a hemostatic agent, and a binder. The dressing is designed to expedite hemostasis, improve antimicrobial activity, minimize fluid loss, and accelerate wound healing when applied to a wound. It is particularly beneficial for military in-theater medical care and conditions such as diabetic foot ulcers, among other applications. He has 1 patent to his name.

Career Highlights

Vivek is currently associated with Arteriocyte Inc., where he continues to innovate in the field of medical devices. His work focuses on developing solutions that enhance patient care and improve outcomes in wound management.

Collaborations

Some of his notable coworkers include Meghan Elizabeth Samberg and Kolby Luke Day. Their collaborative efforts contribute to the advancement of medical technologies at Arteriocyte Inc.

Conclusion

Vivek Prabhakar Raut is a pioneering inventor whose work in wound care technology is making a significant impact. His innovative dressing has the potential to transform how wounds are treated, ultimately improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…